ATR and cancer: It also induces immunogenic cell death (ICD)7 that increases cancer cell adjuvanticity and drives the host immune system to mount a stronger antitumor effector function.8, 10 We identified the ataxia telangiectasia and Rad3-related protein (ATR) kinase as a new target involved in oxaliplatin resistance.11